MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA-c
Peptide encoded in mitochondrial DNA, studied for metabolism and exercise in animals.
Evidence
Emerging
FDA status
Not FDA-approved
Source
Mitochondrially-encoded peptide, synthesized therapeutically
Overview
Peptide encoded in mitochondrial DNA, studied for metabolism and exercise in animals.
Mechanism of Action
Activates FoxO transcription factors for stress resilience, enhances mitochondrial autophagy (mitophagy), promotes mitochondrial biogenesis, improves glucose and fat metabolism, increases insulin sensitivity, mimics caloric restriction pathways.
What research has looked at
Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.
- Enhances metabolic efficiency
- Improves insulin sensitivity
- Promotes mitochondrial biogenesis
- Aging pathways in animal models
- Increases energy utilization
- Supports exercise performance
- Caloric-restriction-like effects in mice
Researched for
Research topics, not approved uses.
How Gabriel approaches peptides
MOTS-c can be requested through Gabriel. A licensed clinician at a telehealth partner reviews your request and decides whether it's appropriate. Gabriel never gives peptide dosing.
Compounded medications aren't FDA-approved. A licensed clinician decides what's right for you.
Research & Evidence
Animal studies, human observational data
Metabolic effects are reported in mice. Human data are limited to measuring natural MOTS-c levels; there are no controlled trials of taking it.
Safety Information
Potential Side Effects
- •Injection site reactions
- •Transient fatigue
Contraindications
- Pregnancy
- Breastfeeding
Interactions
- ⚠May enhance metformin effects